De Backer Marianne 4
4 · Vir Biotechnology, Inc. · Filed Apr 4, 2025
Insider Transaction Report
Form 4
De Backer Marianne
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-04-03$5.95/sh−79,712$474,239→ 769,505 total
Holdings
- 53,118(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]The shares are held in the name of the Ureel-De Backer Family Trust, of which the reporting person and her spouse are Trustees.